Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Withdrawn before enrolling · Phase 1/Phase 2
Conditions studied: Crohn's Disease
In brief
The purpose of this study is to determine the best role for capsule endoscopy in diagnosing Crohn's disease.
Key facts
- Study ID
- NCT00178438
- Run by
- University of Rochester
- People needed
- 0
- Starts
- 2005-06-01
- Expected to finish
- 2006-06-01
- Last updated by the study team
- 2015-09-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- English speaking adult patients (>18 years old) with known Crohn's disease
You may not qualify if…
- Severe medical or psychiatric co-morbidities
- Active swallowing problems
- Bowel obstruction
- History of stricture or fistula
- Pregnancy
- Taking aspirin/non-steroidal anti-inflammatory drug (NSAID) or potassium chloride (KCl) within 4 weeks prior to the colonoscopy and anytime after colonoscopy
- Inability to consent
- Exclusion of patients whose colonoscopy was done for reasons other than signs/symptoms suggestive of Crohn's disease
Where it is running
- University of Rochester Medical Center — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.